Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 AUD | +0.46% | +0.23% | +2.26% |
04-02 | Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 | MT |
03-26 | Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.26% | 4.19B | |
+13.78% | 68.39B | |
+14.85% | 18.61B | |
+20.86% | 13.54B | |
+5.85% | 13.22B | |
+16.72% | 10.03B | |
-24.59% | 6.2B | |
-6.97% | 5.65B | |
+0.31% | 5.05B | |
-3.01% | 4.82B |
- Stock Market
- Equities
- ALQ Stock
- News ALS Limited
- ALS : Acquires 49% Stake in European Pharmaceutical Testing Firm Nuvisan